Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055701) titled 'Study on health status assessment utilizing salivary biomarkers' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - NISSHIN PHARMA INC.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To confirm that health status can be evaluated utilizing salivary biomarkers
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - (1) Healthy Subjects employed at Nissin Pharma Co., Ltd., aged 20 years or older at the time of obtaining consent
(2) Subjects who have received a sufficient explanation of the study, are able to understand its contents, and can provide written consent
(3) Subjects who have not been diagnosed with sleep disorders or periodontal disease
Key exclusion criteria - (1) Subjects who are currently participating in clinical trials of other drugs or health foods, who are within 4 weeks of completing a clinical trial, or who plan to participate in another clinical trial after agreeing to participate in this study
(2) Subjects for whom it is difficult to collect saliva samples
(3) Subjects who the principal investigator judges to be inappropriate to participate in this study
Target Size - 5
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2024 Year 08 Month 22 Day
Anticipated trial start date - 2024 Year 09 Month 13 Day
Last follow-up date - 2025 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063554
Disclaimer: Curated by HT Syndication.
